88 related articles for article (PubMed ID: 26360610)
1. POL5551, a novel and potent CXCR4 antagonist, enhances sensitivity to chemotherapy in pediatric ALL.
Sison EA; Magoon D; Li L; Annesley CE; Romagnoli B; Douglas GJ; Tuffin G; Zimmermann J; Brown P
Oncotarget; 2015 Oct; 6(31):30902-18. PubMed ID: 26360610
[TBL] [Abstract][Full Text] [Related]
2. The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor.
Karpova D; Dauber K; Spohn G; Chudziak D; Wiercinska E; Schulz M; Pettit AR; Levesque JP; Romagnoli B; Patel K; Chevalier E; Dembowsky K; Bonig H
Leukemia; 2013 Dec; 27(12):2322-31. PubMed ID: 24072044
[TBL] [Abstract][Full Text] [Related]
3. Multifaceted C-X-C Chemokine Receptor 4 (CXCR4) Inhibition Interferes with Anti-Vascular Endothelial Growth Factor Therapy-Induced Glioma Dissemination.
Gagner JP; Sarfraz Y; Ortenzi V; Alotaibi FM; Chiriboga LA; Tayyib AT; Douglas GJ; Chevalier E; Romagnoli B; Tuffin G; Schmitt M; Lemercier G; Dembowsky K; Zagzag D
Am J Pathol; 2017 Sep; 187(9):2080-2094. PubMed ID: 28734730
[TBL] [Abstract][Full Text] [Related]
4. Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma.
Barone A; Sengupta R; Warrington NM; Smith E; Wen PY; Brekken RA; Romagnoli B; Douglas G; Chevalier E; Bauer MP; Dembowsky K; Piwnica-Worms D; Rubin JB
Oncotarget; 2014 Oct; 5(20):9811-22. PubMed ID: 25238146
[TBL] [Abstract][Full Text] [Related]
5. BACH2-mediated FOS confers cytarabine resistance via stromal microenvironment alterations in pediatric ALL.
Zhang H; Zhang R; Zheng X; Sun M; Fan J; Fang C; Tian X; Zheng H
Cancer Sci; 2021 Mar; 112(3):1235-1250. PubMed ID: 33393145
[TBL] [Abstract][Full Text] [Related]
6. CXCL12/CXCR4 axis in the pathogenesis of acute lymphoblastic leukemia (ALL): a possible therapeutic target.
de Lourdes Perim A; Amarante MK; Guembarovski RL; de Oliveira CE; Watanabe MA
Cell Mol Life Sci; 2015 May; 72(9):1715-23. PubMed ID: 25572297
[TBL] [Abstract][Full Text] [Related]
7. Overcoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia.
Tarighat SS; Fei F; Joo EJ; Abdel-Azim H; Yang L; Geng H; Bum-Erdene K; Grice ID; von Itzstein M; Blanchard H; Heisterkamp N
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830047
[TBL] [Abstract][Full Text] [Related]
8. General anaesthetics reduce acute lymphoblastic leukaemia malignancies
Jiang C; Gonzalez-Anton S; Li X; Mi E; Wu L; Zhao H; Zhang G; Lu A; Lo Celso C; Ma D
F1000Res; 2022; 11():1491. PubMed ID: 38798305
[TBL] [Abstract][Full Text] [Related]
9. Stromal cell-mediated mitochondrial redox adaptation regulates drug resistance in childhood acute lymphoblastic leukemia.
Liu J; Masurekar A; Johnson S; Chakraborty S; Griffiths J; Smith D; Alexander S; Dempsey C; Parker C; Harrison S; Li Y; Miller C; Di Y; Ghosh Z; Krishnan S; Saha V
Oncotarget; 2015 Dec; 6(40):43048-64. PubMed ID: 26474278
[TBL] [Abstract][Full Text] [Related]
10. Cell surface expression of GRP78 and CXCR4 is associated with childhood high-risk acute lymphoblastic leukemia at diagnostics.
Angeles-Floriano T; Rivera-Torruco G; García-Maldonado P; Juárez E; Gonzalez Y; Parra-Ortega I; Vilchis-Ordoñez A; Lopez-Martinez B; Arriaga-Pizano L; Orozco-Ruíz D; Torres-Nava JR; Licona-Limón P; López-Sosa F; Bremer A; Alvarez-Arellano L; Valle-Rios R
Sci Rep; 2022 Feb; 12(1):2322. PubMed ID: 35149705
[TBL] [Abstract][Full Text] [Related]
11. A CXCR4 antagonist leads to tumor suppression by activation of immune cells in a leukemia-induced microenvironment.
Han AR; Lee JY; Kim HJ; Min WS; Park G; Kim SH
Oncol Rep; 2015 Dec; 34(6):2880-8. PubMed ID: 26398122
[TBL] [Abstract][Full Text] [Related]
12. Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway.
Xu D; Li R; Wu J; Jiang L; Zhong HA
Curr Top Med Chem; 2016; 16(13):1441-51. PubMed ID: 26369824
[TBL] [Abstract][Full Text] [Related]
13. EPI-X4, a novel endogenous antagonist of CXCR4.
Buske C; Kirchhoff F; Münch J
Oncotarget; 2015 Nov; 6(34):35137-8. PubMed ID: 26459389
[No Abstract] [Full Text] [Related]
14. Bone marrow microenvironment modulation of acute lymphoblastic leukemia phenotype.
Moses BS; Slone WL; Thomas P; Evans R; Piktel D; Angel PM; Walsh CM; Cantrell PS; Rellick SL; Martin KH; Simpkins JW; Gibson LF
Exp Hematol; 2016 Jan; 44(1):50-9.e1-2. PubMed ID: 26407636
[TBL] [Abstract][Full Text] [Related]
15. Thymic-Epithelial-Cell-Dependent Microenvironment Influences Proliferation and Apoptosis of Leukemic Cells.
Patel SK; Zhdanovskaya N; Sergio I; Cardinale A; Rosichini M; Varricchio C; Pace E; Capalbo C; Locatelli F; Macone A; Velardi E; Palermo R; Felli MP
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338689
[TBL] [Abstract][Full Text] [Related]
16. CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment.
Bao S; Darvishi M; H Amin A; Al-Haideri MT; Patra I; Kashikova K; Ahmad I; Alsaikhan F; Al-Qaim ZH; Al-Gazally ME; Kiasari BA; Tavakoli-Far B; Sidikov AA; Mustafa YF; Akhavan-Sigari R
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7945-7968. PubMed ID: 36905421
[TBL] [Abstract][Full Text] [Related]
17. Fast H3K9 methylation promoted by CXCL12 contributes to nuclear changes and invasiveness of T-acute lymphoblastic leukemia cells.
Madrazo E; González-Novo R; Ortiz-Placín C; García de Lacoba M; González-Murillo Á; Ramírez M; Redondo-Muñoz J
Oncogene; 2022 Feb; 41(9):1324-1336. PubMed ID: 34999734
[TBL] [Abstract][Full Text] [Related]
18. Targeting chemokines for acute lymphoblastic leukemia therapy.
Hong Z; Wei Z; Xie T; Fu L; Sun J; Zhou F; Jamal M; Zhang Q; Shao L
J Hematol Oncol; 2021 Mar; 14(1):48. PubMed ID: 33743810
[TBL] [Abstract][Full Text] [Related]
19. Facts and Challenges in Immunotherapy for T-Cell Acute Lymphoblastic Leukemia.
Bayón-Calderón F; Toribio ML; González-García S
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081391
[TBL] [Abstract][Full Text] [Related]
20. Targeting CXCR4 in AML and ALL.
Cancilla D; Rettig MP; DiPersio JF
Front Oncol; 2020; 10():1672. PubMed ID: 33014834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
